Qube Research & Technologies LTD Becton Dickinson & CO Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Qube Research & Technologies LTD holds 683,669 shares of BDX stock, worth $153 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
683,669
Previous 1,027,822
33.48%
Holding current value
$153 Million
Previous $248 Million
37.41%
% of portfolio
0.21%
Previous 0.38%
Shares
21 transactions
Others Institutions Holding BDX
# of Institutions
1,803Shares Held
260MCall Options Held
1.27MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA26.7MShares$5.99 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.99 Billion0.12% of portfolio
-
State Street Corp Boston, MA14.1MShares$3.16 Billion0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$2.77 Billion0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.1MShares$2.72 Billion1.7% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $63.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...